Elizabeth Yeu Lin, Chief Medical Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 11,578 shares at $73.86 ($898K) on 2026-09-01, disclosed to the SEC on 2026-09-03.
Scheduled sale ($898k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.86 | 4,601 | $340K | 37.8% |
| 2 | $80.00 | 1,590 | $127K | 14.2% |
| 3 | $80.00 | 5,387 | $431K | 48.0% |
| Total | $77.56 avg | 11,578 | $898K | 100% |
| Filing → |
| TARS | SELL | 2025-12-17 | $165K | — | Filing → |
| TARS | SELL | 2025-06-17 | $41K | — | Filing → |
| STAA | BUY | 2023-09-22 | $100K | — | Filing → |